Holen Sie sich die Stockscreener-App
0.7715
0.54%
-0.0042
Schlusskurs vom Vortag:
$0.7757
Offen:
$0.7753
24-Stunden-Volumen:
121.95K
Relative Volume:
0.26
Marktkapitalisierung:
$63.81M
Einnahmen:
$38.70M
Nettoeinkommen (Verlust:
$-117.88M
KGV:
-0.4538
EPS:
-1.7
Netto-Cashflow:
$-92.84M
1W Leistung:
+1.58%
1M Leistung:
+17.25%
6M Leistung:
-16.31%
1J Leistung:
-48.91%
1-Tages-Spanne:
$0.7551
$0.78
1-Wochen-Bereich:
$0.722
$0.8197
52-Wochen-Spanne:
$0.4471
$1.70
Adicet Bio Inc Stock (ACET) Company Profile
Firmenname
Adicet Bio Inc
Sektor
Branche
Telefon
617-482-2333
Adresse
131 DARTMOUTH STREET, BOSTON
Vergleichen Sie ACET mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
0.7715 | 64.16M | 38.70M | -117.88M | -92.84M | -1.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-30 | Fortgesetzt | Guggenheim | Buy |
| 2024-09-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-06-27 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-06-27 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-06-01 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-09-21 | Eingeleitet | JP Morgan | Overweight |
| 2022-03-31 | Eingeleitet | SMBC Nikko | Outperform |
| 2022-03-08 | Eingeleitet | Truist | Buy |
| 2022-03-04 | Eingeleitet | Jefferies | Buy |
| 2021-05-18 | Eingeleitet | BTIG Research | Buy |
| 2021-04-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-14 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-04-08 | Eingeleitet | Guggenheim | Buy |
| 2020-11-04 | Eingeleitet | B. Riley Securities | Buy |
| 2020-10-27 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-16 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Adicet Bio Inc Aktie (ACET) Neueste Nachrichten
Why is Adicet Bio Inc. stock attracting strong analyst attentionDiscover undervalued stocks before they soar - jammulinksnews.com
What makes Adicet Bio Inc. stock price move sharplyFree Deep Market Trend Analysis - Newser
How high can Adicet Bio Inc. stock price go in 2025Free Long-Term Wealth Growth Plan - Newser
Adicet Bio (NASDAQ:ACET) Upgraded by HC Wainwright to Strong-Buy Rating - Defense World
Adicet Bio’s (ACET) “Buy” Rating Reiterated at HC Wainwright - Defense World
Q2 Earnings Estimate for Adicet Bio Issued By HC Wainwright - Defense World
Everest Medicines raises $200M; Epirium Bio targets $55M Series B - Endpoints News
Does Adicet Bio Inc. stock pay reliable dividendsOutperformance with explosive growth - jammulinksnews.com
Adicet Bio doses first SSc subject in second cohort of trial evaluating ADI-001 - Yahoo Finance
Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases - BioSpace
Is Adicet Bio Inc. a good long term investmentRapid portfolio appreciation - PrintWeekIndia
What drives Adicet Bio Inc. stock priceConsistently profitable trades - Autocar Professional
Adicet Bio doses first systemic sclerosis patient in ADI-001 trial By Investing.com - Investing.com South Africa
Adicet Bio doses first systemic sclerosis patient in ADI-001 trial - Investing.com Nigeria
Adicet Bio Announces 30% Workforce Reduction Strategy - TipRanks
Adicet Bio stock rating initiated at Buy by H.C. Wainwright - Investing.com Australia
What analysts say about Adicet Bio Inc. stockPhenomenal capital appreciation - jammulinksnews.com
Adicet Bio Inc. Stock Analysis and ForecastOutstanding risk-reward balance - jammulinksnews.com
Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Esophageal Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis Miltenyi Biomedicine, Adicet Bio, Velosbio, Novartis Pharmaceuticals, Sanofi, - MenaFN
How Adicet Bio Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser
Why Adicet Bio Inc. stock attracts strong analyst attentionSmart High Yield Swing Trades - Newser
Diffuse Large B-Cell Lymphoma Clinical Trails, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, And Pipeline Analysis Miltenyi Biomedicine, Adicet Bio, Velosbio, Novartis Pharmaceu - MenaFN
Adicet Bio, Inc. (NASDAQ:ACET) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Adicet Bio Elects Directors and Approves Key Proposals - TipRanks
Adicet Bio, Inc. (NASDAQ:ACET) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Squarepoint Ops LLC Purchases New Shares in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio To Present At Jefferies Global Healthcare Conference; Webcast At 4:20 PM ET - Nasdaq
Northern Trust Corp Acquires 28,153 Shares of Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
ACETAdicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - Revista ADVFN
Millennium Management LLC Lowers Position in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Finanzdaten der Adicet Bio Inc-Aktie (ACET)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):